CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income	$ 104,383	$ 47,087
Reconciliation of net income to net cash provided by operating activities:
Depreciation and amortization	25,991	27,480
Deferred financing cost amortization	133	126
Stock-based compensation	8,034	6,546
Provision for expected credit losses	224	112
Inventory obsolescence	1,642	2,462
Gain on disposal of assets	(470)	(1,136)
Deferred income taxes	19,230	(1,404)
(Gain) loss from revaluation of liability related to tax receivable agreement	(10)	1,004
Changes in operating assets and liabilities:
Accounts receivable	(42,906)	(35,634)
Inventories	(45,545)	(16,491)
Prepaid expenses and other assets	(4,265)	(4,239)
Accounts payable	20,537	22,944
Accrued expenses and other liabilities	3,293	12,924
Payments pursuant to tax receivable agreement	(11,666)	(9,697)
Net cash provided by operating activities	78,605	52,084
Cash flows from investing activities
Capital expenditures and other	(21,197)	(10,382)
Proceeds from sale of assets	1,701	1,965
Net cash used in investing activities	(19,496)	(8,417)
Cash flows from financing activities
Payment of deferred financing costs	(165)	0
Payments on finance leases	(4,505)	(3,839)
Dividends paid to Class A common stock shareholders	(20,015)	(15,249)
Distributions to members	(8,007)	(8,074)
Repurchases of shares	(4,495)	(3,192)
Net cash used in financing activities	(37,187)	(30,354)
Effect of exchange rate changes on cash and cash equivalents	(2,968)	2
Net increase in cash and cash equivalents	18,954	13,315
Cash and cash equivalents
Beginning of period	301,669	288,659
End of period	320,623	301,974
Supplemental disclosure of cash flow information
Right-of-use assets obtained in exchange for new lease obligations	10,707	11,958
Property and equipment in accounts payable	$ 1,582	$ 479